MenoGeniX

About:

MenoGeniX is a clinical stage biotechnology company focusing on the development of drugs for menopause.

Website: https://www.menogenix.com/

Top Investors: National Institutes of Health

Description:

MenoGeniX, Inc., a clinical stage biotechnology company, focuses on the development of drugs for menopause and the menopause-like symptoms that occur in breast and prostate cancer patients. The company was founded in 2010 and is based in Aurora, Colorado.

Total Funding Amount:

$1.11M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Aurora, Colorado, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)menogenix.com

Founders:

Debra M. Duke, Douglas Farrar

Number of Employees:

1-10

Last Funding Date:

2018-05-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai